212
Views
10
CrossRef citations to date
0
Altmetric
Underserved Populations

Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma

, MD, MS, , MS, , MD & , PhD, MS
Pages 504-513 | Received 29 Apr 2016, Accepted 15 Sep 2016, Published online: 21 Dec 2016

References

  • Berair R, Brightling CE. Asthma therapy and its effect on airway remodeling. Drugs 2014;74(12):1345–1369.
  • Akinbami LJ, Moorman JE, Bailey C. Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS Data Brief 2012;(94):1–8.
  • Centers for Disease Control and Prevention. Asthma's Impact on the Nation. Available from http://www.cdc.gov/asthma/impacts_nation/AsthmaFactSheet.pdf [last accessed 20 August 2015].
  • Global strategy for asthma management and prevention Update 2015. Global Initiative for Asthma. Available from: http://www.ginasthma.org/local/uploads/files/GINA_Report_2015.pdf [last accessed August 20, 2015].
  • Lindsay JT, Heaney LG. Nonadherence in difficult asthma-facts, myths, and a time to act. Patient Prefer Adherence 2013;7:329–336.
  • Centers for Medicare & Medicaid Services (CMS), HHS. Medicare program; Medicare prescription drug benefit. Final rule. Fed Regist 2005;70(18):4193–4585.
  • Ai AL, Carretta H, Beitsch LM, Watson L, Munn J, Mehriary S. Medication therapy management programs: promises and pitfalls. J Manag Care Spec Pharm 2014;20(12):1162–1182.
  • Ferrell KW, Woodard LM, Woodard TJ. Role of medication therapy management in preexposure prophylaxis therapy for HIV prevention. J Pharm Pract 2015;28(1):10–12.
  • Truong HA, Groves CN, Congdon HB, Dang DT, Botchway R, Thomas J. Potential cost savings of medication therapy management in safety-net clinics. J Am Pharm Assoc (2003) 2015;55(3):269–272.
  • Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm 2010;16(3):185–195.
  • Viswanathan M, Kahwati LC, Golin CE, Blalock SJ, Coker-Schwimmer E, Posey R, et al. Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Intern Med 2015;175(1):76–87.
  • Hui RL, Yamada BD, Spence MM, Jeong EW, Chan J. Impact of a Medicare MTM program: evaluating clinical and economic outcomes. Am J Manag Care 2014;20(2):e43–51.
  • Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc (2003) 2006;46(2):133–147.
  • Gums TH, Carter BL, Milavetz G, Buys L, Rosenkrans K, Uribe L, et al. Physician-pharmacist collaborative management of asthma in primary care. Pharmacotherapy 2014;34(10):1033–1042.
  • 2011 Medicare Part D Medication Therapy Management (MTM) Programs. Centers for Medicare and Medicaid Services. Available from: http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/downloads/MTMFactSheet2011063011Final.pdf. [last accessed 20 August 2015.
  • 2012 Medicare Part D Medication Therapy Management (MTM) Programs. Centers for Medicare and Medicaid Services. Available from: https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/CY2012-MTM-Fact-Sheet.pdf [last accessed 20 August 2015.
  • Snyder ME, Frail CK, Jaynes H, Pater KS, Zillich AJ. Predictors of medication-related problems among Medicaid patients participating in a pharmacist-provided telephonic medication therapy management program. Pharmacotherapy 2014;34(10):1022–1032.
  • Schommer JC, Planas LG, Johnson KA, Doucette WR. Pharmacist-provided medication therapy management (part 2): Payer perspectives in 2007. J Am Pharm Assoc (2003) 2008; 48(4):478–486.
  • Shoemaker SJ, Hassol A. Understanding the landscape of MTM programs for Medicare. Part D: Results from a study for the Centers for Medicare & Medicaid Services. J Am Pharm Assoc (2003) 2011;51(4):520–526.
  • Shimp LA, Kucukarslan SN, Elder J. Employer-based patient-centered medication therapy management program: evidence and recommendations for future programs. J Am Pharm Assoc (2003) 2012;52(6):768–776.
  • Moorman JE, Rudd RA, Johnson CA, et al. National surveillance for asthma-United States, 1980–2004. MMWR Surveill Summ 2007;56(8):1–54.
  • Byrd L, Fletcher A, Menifield C. Disparities in health care: minority elders at risk. ABNF J 2007;18(2):51–55.
  • Lackland DT. Racial differences in hypertension: implications for high blood pressure management. Am J Med Sci 2014;348(2):135–138.
  • Peek ME, Cargill A, Huang ES. Diabetes health disparities: a systematic review of health care interventions. Med Care Res Rev 2007;64(5 Suppl):101S–56S.
  • Wang J, White-Means SI, Hufstader MA, Walker GD. The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors. Curr Med Res Opin 2007;23(4):853–863.
  • Wang J, Zuckerman IH, Miller NA, Shaya FT, Noel JM, Mullins CD. Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Health Serv Res 2007;42(4):1499–1519.
  • Schore J, Brown R, Lavin B. Racial disparities in prescription drug use among dually eligible beneficiaries. Health Care Financ Rev 2003;25(2):77–90.
  • Gaskin DJ, Briesacher BA, Limcangco R, Brigantti BL. Exploring racial and ethnic disparities in prescription drug spending and use among Medicare beneficiaries. Am J Geriatr Pharmacother 2006;4(2):96–111.
  • Cook BL, Manning WG. Measuring racial/ethnic disparities across the distribution of health care expenditures. Health Serv Res 2009;44(5 Pt 1):1603–1621.
  • Wang J, Brown LM, Hong SH. Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population. J Am Pharm Assoc (2003). 2012;52: e87–96.
  • Wang J, Qiao Y. Historical trend of disparity implications of Medicare MTM eligibility criteria. Res Social Adm Pharm 2013;9(6):758–769.
  • Wang J, Zhang Z, Spivey CA, Chisholm-Burns M. Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population. Res Social Adm Pharm 2014;10(6):904–917.
  • Gorman BK, Chu M. Racial and ethnic differences in adult asthma prevalence, problems, and medical care. Ethn Health 2009;14(5):527–552.
  • Asthma facts. Department of Health & Human Services CDC's National Asthma Control Program Grantees. Available from: http://www.cdc.gov/asthma/pdfs/asthma_facts_program_grantees.pdf [last accessed 20 August 2015].
  • Medical Expenditure Panel Survey. Agency for Healthcare Research and Quality. Available from: http://meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp. [last accessed 20 August 2015].
  • Marcus P, Braman SS. International classification of disease coding for obstructive lung disease: does it reflect appropriate clinical documentation? Chest 2010;138(1):188–192.
  • Andersen RM, Rice TH, Kominski GF, eds. Changing the U.S. Health Care System: Key Issues in Health Services Policy and Management. 3rd ed. San Francisco, CA: Jossey-Bass; 2007.
  • Jahangir E, Irazola V, Rubinstein A. Need, enabling, predisposing, and behavioral determinants of access to preventative care in Argentina: analysis of the national survey of risk factors. PLoS One 2012;7(9):e45053.
  • Wang J, Mullins CD, Brown LM, Shih YC, Dagogo-Jack S, Hong SH, et al. Disparity implications of Medicare eligibility criteria for medication therapy management services. Health Serv Res 2010;45(4):1061–1082.
  • Daniel GW, Malone DC. Characteristics of older adults who meet the annual prescription drug expenditure threshold for Medicare medication therapy management programs. J Manag Care Pharm. 2007;13(2):142–154.
  • Lee DC, Shi L, Pierre G, Zhu J, Hu R. Chronic conditions and medical expenditures among non-institutionalized adults in the United States. Int J Equity Health 2014;13(1):105.
  • Naessens JM, Stroebel RJ, Finnie DM, Shah ND, Wagie AE, Litchy WJ, et al. Effect of multiple chronic conditions among working-age adults. Am J Manag Care 2011;17(2):118–122.
  • Halm EA, Wisnivesky JP, Leventhal H. Quality and access to care among a cohort of inner-city adults with asthma: who gets guideline concordant care? Chest 2005;128(4):1943–1950.
  • Le TT, Bilderback A, Bender B, Wamboldt FS, Turner CF, Rand CS, et al. Do asthma medication beliefs mediate the relationship between minority status and adherence to therapy? J Asthma 2008;45(1):33–37.
  • Wolfenden LL, Diette GB, Krishnan JA, Skinner EA, Steinwachs DM, Wu AW. Lower physician estimate of underlying asthma severity leads to undertreatment. Arch Intern Med 2003;163(2):231–236.
  • Okelo SO, Wu AW, Merriman B, Krishnan JA, Diette GB. Are physician estimates of asthma severity less accurate in black than in white patients? J Gen Intern Med 2007;22(7):976–981.
  • Sondik EJ, Huang DT, Klein RJ, Satcher D. Progress toward the healthy people 2010 goals and objectives. Annu Rev Public Health 2010;31:271–281.
  • Disparities. Healthy People 2020. HealthyPeople.gov Website. Available from: http://www.healthypeople.gov/2020/about/foundation-health-measures/Disparities [last accessed 20 August 2015].
  • Rucker NL. Medicare Part D's medication therapy management: shifting from neutral to drive. Insight on the Issues. Available from: http://www.aarp.org/content/dam/aarp/research/public_policy_institute/health/medi-care-part-d-shifting-from-neutral-to-drive-insight-AARP-ppi-health.pdf. Published on June 2012 [last accessed August 20, 2015].
  • Centers for Medicare & Medicaid Services (CMS), HHS. Medicare program; Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs. Final rule. Fed Regist 2014 May 23;79(100):29843–29968.
  • Stuart B, Loh E, Miller L, Roberto P. Should eligibility for medication therapy management be based on drug adherence? J Manag Care Pharm 2014;20(1):66–75.
  • Wang J, Qiao Y, Tina Shih YC, et al. Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria. J Pharm Health Serv Res 2014;5(2):109–118.
  • Weakley J, Webber MP, Ye F, Zeig-Owens R, Cohen HW, Hall CB, et al. Agreement between obstructive airways disease diagnoses from self-report questionnaires and medical records. Prev Med 2013;57(1):38–42.
  • Bai JR, Mukherjee DV, Befus M, Apa Z, Lowy FD, Larson EL. Concordance between medical records and interview data in correctional facilities. BMC Med Res Methodol 2014;14:50.
  • Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123(5):894–900.
  • Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004;57(10):1096–1103.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.